D. Dell

615 total citations
21 papers, 534 citations indexed

About

D. Dell is a scholar working on Pharmacology, Organic Chemistry and Analytical Chemistry. According to data from OpenAlex, D. Dell has authored 21 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 6 papers in Organic Chemistry and 6 papers in Analytical Chemistry. Recurrent topics in D. Dell's work include Antibiotics Pharmacokinetics and Efficacy (11 papers), Analytical Methods in Pharmaceuticals (6 papers) and Cancer therapeutics and mechanisms (4 papers). D. Dell is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (11 papers), Analytical Methods in Pharmaceuticals (6 papers) and Cancer therapeutics and mechanisms (4 papers). D. Dell collaborates with scholars based in Switzerland, United Kingdom and Israel. D. Dell's co-authors include Michael Wall, U. Timm, Renée Portmann, E. Weidekamm, Joseph P. Chamberlain, Katja Suter, P W Lücker, Robert A. Shaw, Β. W. Fitzsimmons and Jason D. Coombes and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Chromatography A and Journal of Pharmaceutical Sciences.

In The Last Decade

D. Dell

21 papers receiving 483 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
D. Dell 289 114 98 90 82 21 534
Lawrence T. Sennello 220 0.8× 77 0.7× 72 0.7× 56 0.6× 102 1.2× 26 469
Arlyn W. Kinkel 176 0.6× 102 0.9× 113 1.2× 31 0.3× 89 1.1× 27 794
M.C. Rouan 212 0.7× 106 0.9× 135 1.4× 50 0.6× 198 2.4× 31 941
C. Souppart 175 0.6× 117 1.0× 130 1.3× 24 0.3× 53 0.6× 24 706
Constantin Efthymiopoulos 130 0.4× 96 0.8× 46 0.5× 49 0.5× 215 2.6× 16 636
Thomas Mercier 184 0.6× 136 1.2× 76 0.8× 42 0.5× 108 1.3× 33 685
Michael Schleimer 153 0.5× 114 1.0× 130 1.3× 80 0.9× 155 1.9× 19 861
P. G. Welling 177 0.6× 72 0.6× 44 0.4× 46 0.5× 42 0.5× 9 409
H Vergin 177 0.6× 81 0.7× 95 1.0× 14 0.2× 79 1.0× 56 544
Fred C. Falkner 108 0.4× 109 1.0× 64 0.7× 22 0.2× 50 0.6× 27 512

Countries citing papers authored by D. Dell

Since Specialization
Citations

This map shows the geographic impact of D. Dell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Dell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Dell more than expected).

Fields of papers citing papers by D. Dell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Dell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Dell. The network helps show where D. Dell may publish in the future.

Co-authorship network of co-authors of D. Dell

This figure shows the co-authorship network connecting the top 25 collaborators of D. Dell. A scholar is included among the top collaborators of D. Dell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Dell. D. Dell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dell, D.. (2004). Labile Metabolites. Chromatographia. 59(S2). 29 indexed citations
2.
Heizmann, P., et al.. (1990). Determination of the new fluoroquinolone fleroxacin and its N-demethyl and N-oxide metabolites in plasma and urine by high-performance liquid chromatography with fluorescence detection. Journal of Chromatography B Biomedical Sciences and Applications. 527(1). 91–101. 28 indexed citations
3.
Weidekamm, E., et al.. (1988). Single and multiple dose pharmacokinetics of fleroxacin. Journal of Antimicrobial Chemotherapy. 22(Supplement_D). 145–154. 29 indexed citations
5.
Weidekamm, E., K. Stöckel, & D. Dell. (1987). A new trifluorinated quinolone: Ro 23-6240 (AM 833).. PubMed. 13(2). 85–90. 8 indexed citations
6.
Weidekamm, E., et al.. (1987). Single- and multiple-dose pharmacokinetics of fleroxacin, a trifluorinated quinolone, in humans. Antimicrobial Agents and Chemotherapy. 31(12). 1909–1914. 82 indexed citations
7.
Timm, U., Michael Wall, & D. Dell. (1985). A New Approach for Dealing with the Stability of Drugs in Biological Fluids. Journal of Pharmaceutical Sciences. 74(9). 972–977. 89 indexed citations
8.
Dell, D., et al.. (1985). Determination of pyrrolidinone in plasma by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 344. 125–136. 7 indexed citations
9.
McDonald, Angela, et al.. (1984). Disposition of cefotaxime in rat, dog and man.. PubMed. 34(12). 1719–23. 7 indexed citations
10.
Dell, D., et al.. (1984). Determination of tenoxicam, and the isolation, identification and determination of Ro 17-6661, its major metabolite, in human urine. Journal of Chromatography A. 317. 483–492. 26 indexed citations
11.
Bergstrand, Robert, A Vedin, Claes Wilhelmsson, et al.. (1984). Intravenous and oral administration of molsidomine, a pharmacodynamic and pharmacokinetic study. European Journal of Clinical Pharmacology. 27(2). 203–208. 9 indexed citations
12.
Dell, D., Joseph P. Chamberlain, & Frédéric Coppin. (1981). Determination of cefotaxime and desacetylcefotaxime in plasma and urine by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 226(2). 431–440. 29 indexed citations
13.
Chamberlain, Joseph P., Jason D. Coombes, D. Dell, et al.. (1980). Metabolism of cefotaxime in animals and man. Journal of Antimicrobial Chemotherapy. 6(suppl A). 69–78. 67 indexed citations
14.
Dell, D., et al.. (1978). Determination of molsidomine in plasma by high-performance liquid column chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 146(3). 465–472. 20 indexed citations
15.
CUMMINGS, A. J., et al.. (1972). Elimination of 4-n-Butoxyphenylacethydroxamic Acid (Bufexamac) in Man. Journal of Pharmaceutical Sciences. 61(2). 164–168. 3 indexed citations
16.
Dell, D., et al.. (1971). Estimation of 4-Butoxyphenylacetohydroxamic Acid Utilizing the Lossen Rearrangement. Journal of Pharmaceutical Sciences. 60(9). 1368–1370. 7 indexed citations
17.
Dell, D., et al.. (1969). Organometallic Studies. XXXI. The Cleavage of Metal‐Carbon Bonds in Cymantrene and Ferrocene by N‐Bromosuccinimide. Israel Journal of Chemistry. 7(6). 779–782. 1 indexed citations
18.
Dell, D., et al.. (1969). Organometallic Studies. XXXII. Iron π‐Complexes of Some Polyunsaturated Terpenes. Israel Journal of Chemistry. 7(6). 783–794. 1 indexed citations
19.
Dell, D., Β. W. Fitzsimmons, Rodney Keat, & Robert A. Shaw. (1966). Phosphorus–nitrogen compounds. Part XXIII. Dimethylaminophenoxycyclotriphosphazatrienes. Journal of the Chemical Society A Inorganic Physical Theoretical. 0(0). 1680–1686. 10 indexed citations
20.
Dell, D., Β. W. Fitzsimmons, & Robert A. Shaw. (1965). 752. Phosphorus–nitrogen compounds. Part XIII. Phenoxy- and p-bromophenoxy-chlorocyclotriphosphazatrienes. Journal of the Chemical Society (Resumed). 0(0). 4070–4073. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026